Resolution of the Working Meeting of Experts in Dermatology: "Possibilities of systemic therapy of atopic dermatitis with selective immunosuppressants"

Abstract

On February 19, 2022, a working meeting of experts on the problem of atopic dermatitis was held in Moscow under the chairmanship of the Director of the State Scientific Center for Dermatovenereology and Cosmetology of the Ministry of Health of Russia, Doctor of Medical Sciences, Professor, Corresponding Member of the Russian Academy of Sciences A.A. Kubanov, Academician of the Russian Academy of Sciences, Chief Freelance Children's Specialist in Preventive Medicine, Head of the Research Institute of Pediatrics and Children's Health of the Central Clinical Hospital of the Russian Academy of Sciences of the Ministry of Science and Higher Education of the Russian Federation, Doctor of Medical Sciences, Professor, Academician of the Russian Academy of Sciences L.S. Namazova-Baranova, Deputy Director for Clinical Work - Chief Physician of the Federal State Budgetary Institution "SSC" Institute of Immunology "FMBA of Russia" Doctor of Medical Sciences, Professor N.I. Ilyina. The meeting raised topical issues of providing medical care, reducing the burden of the disease and improving the quality of life of patients with atopic dermatitis (AD). New possibilities and principles of systemic therapy in patients with moderate and severe AD were discussed. We analyzed data on a new representative of the small molecule class, the selective Janus kinase 1 inhibitor, upadacitinib, which was registered in the Russian Federation in June 2021, in order to determine its place in AD therapy algorithms and the possibility of the impact of therapy with its use on the quality of life of patients and the burden of diseases.